Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topamax to prevent transformation of episodic migraine (INTREPID)
NCT00212810Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of topiramate in migraine, sponsored by Johnson & Johnson. Started Sep 2005; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00212810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212810.